Form 8-K - Current report:
SEC Accession No. 0001193125-25-117299
Filing Date
2025-05-12
Accepted
2025-05-12 07:30:14
Documents
15
Period of Report
2025-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d948488d8k.htm   iXBRL 8-K 27096
2 EX-99.1 d948488dex991.htm EX-99.1 72032
6 GRAPHIC g948488g0510003728220.jpg GRAPHIC 2787
  Complete submission text file 0001193125-25-117299.txt   240783

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mtsr-20250512.xsd EX-101.SCH 2877
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtsr-20250512_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtsr-20250512_pre.xml EX-101.PRE 11725
17 EXTRACTED XBRL INSTANCE DOCUMENT d948488d8k_htm.xml XML 3772
Mailing Address 3 WORLD TRADE CENTER 175 GREENWICH STREET NEW YORK NY 10007
Business Address 3 WORLD TRADE CENTER 175 GREENWICH STREET NEW YORK NY 10007 (212) 784-6595
Metsera, Inc. (Filer) CIK: 0002040807 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42489 | Film No.: 25932579
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)